Maruzen Pharmaceutical Co., Ltd.
Maruzen Pharmaceutical Co., Ltd., commonly referred to as Maruzen, is a prominent player in the pharmaceutical industry, headquartered in AF. Established in the early 20th century, the company has made significant strides in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of prescription medications and over-the-counter solutions. With a strong operational presence in various regions, Maruzen is recognised for its commitment to quality and research-driven approaches. The company’s core offerings include a diverse range of therapeutic agents that address critical health needs, setting them apart through their rigorous quality control and advanced formulation techniques. Maruzen's dedication to excellence has positioned it as a trusted name in the market, with notable achievements in product development and regulatory compliance, reinforcing its reputation as a leader in the pharmaceutical sector.
DitchCarbon Score
How does Maruzen Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Maruzen Pharmaceutical Co., Ltd.'s score of 10 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Maruzen Pharmaceutical Co., Ltd.'s reported carbon emissions
In 2023, Maruzen Pharmaceutical Co., Ltd. reported total carbon emissions of approximately 62,546,000 kg CO2e. This figure includes 4,482,000 kg CO2e from Scope 1 emissions, 6,690,000 kg CO2e from Scope 2 emissions (market-based), and a significant 51,374,000 kg CO2e from Scope 3 emissions. The Scope 3 emissions are primarily driven by purchased goods and services, which accounted for about 49,249,000 kg CO2e. In 2022, the company’s total emissions were approximately 55,255,000 kg CO2e, with Scope 1 emissions at 4,379,000 kg CO2e and Scope 2 emissions at 6,497,000 kg CO2e (market-based). The Scope 3 emissions for that year were around 44,379,000 kg CO2e. Comparatively, in 2021, Maruzen's total emissions were about 52,205,000 kg CO2e, with Scope 1 emissions of 4,813,000 kg CO2e and Scope 2 emissions of 6,203,000 kg CO2e (market-based). The Scope 3 emissions for 2021 were approximately 44,190,000 kg CO2e. Despite the increase in total emissions from 2021 to 2023, specific reduction targets or initiatives have not been disclosed by Maruzen Pharmaceutical. The company has not committed to any science-based targets or climate pledges, indicating a potential area for future focus in their sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2013 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 4,773,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Maruzen Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
